Your browser doesn't support javascript.
loading
Improving beta-cell secretory function and glycaemia in young-onset type 2 diabetes: A pilot, 12-month, randomized trial of a novel, continuous glucose monitor-guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide.
Middleton, Timothy L; Constantino, Maria I; McGill, Margaret; D'Souza, Mario; Yue, Dennis K; Twigg, Stephen M; Wu, Ted; Wong, Jencia.
Afiliación
  • Middleton TL; Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Constantino MI; RPA Clinic, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.
  • McGill M; Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
  • D'Souza M; Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Yue DK; RPA Clinic, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.
  • Twigg SM; Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
  • Wu T; Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Wong J; RPA Clinic, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.
Diabetes Obes Metab ; 24(4): 747-751, 2022 04.
Article en En | MEDLINE | ID: mdl-34882926
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Liraglutida Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Liraglutida Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Australia